Funding

National Institutes of Health (P01), ‘Immunologic and virologic determinants of congenital cytomegalovirus transmission’, (together with: S. Permar, T. Kowalik, K. Frueh, A. Kaur, P. Barry, S. Pfeifer); 2019-24

dod

U.S. Department of the Army, Congressionally Directed Medical Research Programs; ‘Anticipating influenza resistance evolution: Pathways & Strategies’; (together with: R. Finberg, C. Schiffer, D. Bolon, D. Caffrey, T. Kowalik, W. Marasco, Q. Zhu, J. Wang); 2015-20

Illumina Innovative Investigators Program, ‘Characterizing human cytomegalovirus in a Bolivian population’; (together with: T. Kowalik, S. Pfeifer, B. Trumble); 2017-2018

Center for Evolution & Medicine Venture Fund, ‘The evolutionary history of cytomegalovirus infection in native American populations’; (together with: B. Trumble, S. Pfeifer); 2017-2018

fns

Swiss National Science Foundation, The population genetics of adaptation’ (renewal); 2015-18

erc

European Research Council, Describing Evolution with Theoretical, Empirical, and Computational Tools’; 2013-18

fns

Swiss National Science Foundation, Genetic basis of adaptive change: the demographic and selective history of camouflaged deer mouse populations’; (together with: H. Hoekstra, L. Excoffier); 2012-15

fns

Swiss National Science Foundation, The population genetics of adaptation’; 2012-15

DARPA

U.S. Defense Advanced Research Projects Agency, Algorithms to limit viral epidemics’; (together with: R. Finberg, J. Wang, T. Kowalik, D. Caffrey, N. Renzette, D. Bolon, C. Schiffer, W. Marasco, K. Zeldovich); 2011-14

nsf

U.S. National Science Foundation, Characterizing the process of adaptation’; 2010-11

nsf

U.S. National Science Foundation, Biological Informatics Postdoc Fellowship; ‘Identifying cis-acting binding sites for dosage compensation’; 2006-08